Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide and their combination in severe asthma: a post-hoc analysis

Ítems similars

• Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma
  per: Shrimanker, R, et al.
  Publicat: (2018)
• Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
  per: Price, D, et al.
  Publicat: (2019)
• Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
  per: David B. Price, et al.
  Publicat: (2019-08-01)
• Diagnostic possibility of the combination of exhaled nitric oxide and blood eosinophil count for eosinophilic asthma
  per: Jiang-Hua Li, et al.
  Publicat: (2021-08-01)
• Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
  per: Howell, I, et al.
  Publicat: (2024)